Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity

Nature volume 446, pages 916–920 (2007)Cite this article

Abstract

Retinoic-acid-inducible gene-I (RIG-I; also called DDX58) is a cytosolic viral RNA receptor that interacts with MAVS (also called VISA, IPS-1 or Cardif) to induce type I interferon-mediated host protective innate immunity against viral infection1,2,3,4,5,6. Furthermore, members of the tripartite motif (TRIM) protein family, which contain a cluster of a RING-finger domain, a B box/coiled-coil domain and a SPRY domain, are involved in various cellular processes, including cell proliferation and antiviral activity7. Here we report that the amino-terminal caspase recruitment domains (CARDs) of RIG-I undergo robust ubiquitination induced by TRIM25 in mammalian cells. The carboxy-terminal SPRY domain of TRIM25 interacts with the N-terminal CARDs of RIG-I; this interaction effectively delivers the Lys 63-linked ubiquitin moiety to the N-terminal CARDs of RIG-I, resulting in a marked increase in RIG-I downstream signalling activity. The Lys 172 residue of RIG-I is critical for efficient TRIM25-mediated ubiquitination and for MAVS binding, as well as the ability of RIG-I to induce antiviral signal transduction. Furthermore, gene targeting demonstrates that TRIM25 is essential not only for RIG-I ubiquitination but also for RIG-I-mediated interferon-β production and antiviral activity in response to RNA virus infection. Thus, we demonstrate that TRIM25 E3 ubiquitin ligase induces the Lys 63-linked ubiquitination of RIG-I, which is crucial for the cytosolic RIG-I signalling pathway to elicit host antiviral innate immunity.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Figure 1: The 2CARD of RIG-I undergoes robust ubiquitination.
Figure 2: Interaction between RIG-I and TRIM25.
Figure 3: TRIM25 is a primary E3 ubiquitin ligase of RIG-I.
Figure 4: Role of TRIM25-mediated ubiquitination in RIG-I antiviral activity.

References

  1. Honda, K., Takaoka, A. & Taniguchi, T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349–360 (2006); erratum 25, 849 (2006).

    Article  CAS  Google Scholar 

  2. Hornung, V. et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006)

    Article  ADS  Google Scholar 

  3. Meylan, E. & Tschopp, J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell 22, 561–569 (2006)

    Article  CAS  Google Scholar 

  4. Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314, 997–1001 (2006)

    Article  ADS  CAS  Google Scholar 

  5. Stetson, D. B. & Medzhitov, R. Antiviral defense: interferons and beyond. J. Exp. Med. 203, 1837–1841 (2006)

    Article  CAS  Google Scholar 

  6. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunol. 5, 730–737 (2004)

    Article  CAS  Google Scholar 

  7. Nisole, S., Stoye, J. P. & Saib, A. TRIM family proteins: retroviral restriction and antiviral defence. Nature Rev. Microbiol. 3, 799–808 (2005)

    Article  CAS  Google Scholar 

  8. Johnson, C. L. & Gale, M. CARD games between virus and host get a new player. Trends Immunol. 27, 1–4 (2006)

    Article  CAS  Google Scholar 

  9. Meylan, E., Tschopp, J. & Karin, M. Intracellular pattern recognition receptors in the host response. Nature 442, 39–44 (2006)

    Article  ADS  CAS  Google Scholar 

  10. Kato, H. et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19–28 (2005)

    Article  CAS  Google Scholar 

  11. Orimo, A., Inoue, S., Ikeda, K., Noji, S. & Muramatsu, M. Molecular cloning, structure, and expression of mouse estrogen-responsive finger protein Efp. Co-localization with estrogen receptor mRNA in target organs. J. Biol. Chem. 270, 24406–24413 (1995)

    Article  CAS  Google Scholar 

  12. Urano, T. et al. Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth. Nature 417, 871–875 (2002)

    Article  ADS  CAS  Google Scholar 

  13. Zou, W. & Zhang, D. E. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 281, 3989–3994 (2006)

    Article  CAS  Google Scholar 

  14. Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172 (2005)

    Article  ADS  CAS  Google Scholar 

  15. Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122, 669–682 (2005)

    Article  CAS  Google Scholar 

  16. Xu, L. G. et al. VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol. Cell 19, 727–740 (2005)

    Article  CAS  Google Scholar 

  17. Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nature Immunol. 6, 981–988 (2005)

    Article  CAS  Google Scholar 

  18. Orimo, A. et al. Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor α. Proc. Natl Acad. Sci. USA 96, 12027–12032 (1999)

    Article  ADS  CAS  Google Scholar 

  19. Haglund, K. & Dikic, I. Ubiquitylation and cell signaling. EMBO J. 24, 3353–3359 (2005)

    Article  CAS  Google Scholar 

  20. Ea, C. K., Deng, L., Xia, Z. P., Pineda, G. & Chen, Z. J. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245–257 (2006)

    Article  CAS  Google Scholar 

  21. Kirkpatrick, D. S., Denison, C. & Gygi, S. P. Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics. Nature Cell Biol. 7, 750–757 (2005)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by US Public Health Service grants (J.U.J.), the exchange programme between Harvard Medical School and the graduate training programme 1071 at the Friedrich-Alexander University Erlangen-Nuremberg, Germany (M.U.G.), and a Korea Research Foundation Grant (C.-H.J.). We thank A. Garcia-Sastre, D.-E. Zhang and S. Whelan for providing reagents, and R. Tomaino and J. Nagel for mass spectrometry. We also thank all members of the Tumor Virology Division, New England Primate Research Center, for discussions.

Author Contributions M.U.G. performed all aspects of this study. Y.C.S., C.-H.J. and C.L. assisted in experimental design and in collecting the data. T.U. and S.I. performed the in vitro ubiquitination assay and generated Trim25-/- MEFs. L.S. and Z.C. generated the MAVS construct and RIG-I antibody. T.O. and S.A. generated the RIG-I construct and RIG-I-/- MEFs. M.U.G. and J.U.J. organized this study and wrote the paper. All authors discussed the results and commented on the manuscript.

Author information

Authors and Affiliations

  1. Department of Microbiology and Molecular Genetics and Tumor Virology Division, New England Primate Research Center, Harvard Medical School, 1 Pine Hill Drive, Southborough, Massachusetts 01772, USA,

    Michaela U. Gack, Young C. Shin, Chul-Hyun Joo, Chengyu Liang & Jae U. Jung

  2. Institute for Clinical and Molecular Virology, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany,

    Michaela U. Gack

  3. Department of Microbiology, University of Ulsan College of Medicine, Seoul 138-736, South Korea,

    Chul-Hyun Joo

  4. Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-8655, Japan,

    Tomohiko Urano & Satoshi Inoue

  5. Research Center for Genomic Medicine, Saitama Medical School, Saitama 350-124-2, Japan,

    Tomohiko Urano & Satoshi Inoue

  6. Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9148, USA,

    Lijun Sun & Zhijian Chen

  7. Department of Host Defense, Japan Science and Technology Agency, Osaka 565-0871, Japan,

    Osamu Takeuchi & Shizuo Akira

Authors
  1. Michaela U. Gack
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Young C. Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chul-Hyun Joo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomohiko Urano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chengyu Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lijun Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Osamu Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shizuo Akira
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zhijian Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Satoshi Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jae U. Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jae U. Jung.

Ethics declarations

Competing interests

Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.

Supplementary information

Supplementary Figures

This file contains Supplementary Figures 1-10 with Legends. The Supplementary Figures provide additional information on the Lys63-linked ubiquitination of RIG-I and the role of RIG-I ubiquitination in its signaling activity. They also show more data to support the essential role of TRIM25-mediated ubiquitination in RIG-I signal transduction and host anti-viral activity. (PDF 3300 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gack, M., Shin, Y., Joo, CH. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916–920 (2007). https://doi.org/10.1038/nature05732

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature05732

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing